AI Summary
We reviewed 58 live results for tnf inhibitor and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Tnf Alpha Inhibitor and Immunosuppressant.
Comparison Table
Recommended
Simponi
Source: Johnson & Johnson Pte. Ltd.
Description
The reference biologic golimumab, a TNF-alpha inhibitor used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. It is available in Singapore as a solution for injection in pre-filled pens (SmartJect) or syringes, and as an intravenous concentrate.
Best for
Singapore-based patients, MAF subsidy applicants and rheumatoid arthritis management
View Details
Rating
Simponi Solution for Injection (Pre-filled Pen/SmartJect)
Source: Johnson & Johnson International (Singapore) Pte Ltd
Description
A biological medication containing the active ingredient Golimumab, packaged in the SmartJect pre-filled pen system for subcutaneous injection. This TNF-alpha inhibitor is designed for adult patients suffering from rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. The delivery system is optimized for ease of patient use during self-administration.
Best for
home self-administration, rheumatoid arthritis management, ulcerative colitis patients and convenient biologic therapy
View Details
Rating
Amgevita / Yuflyma / Hyrimoz (Adalimumab Biosimilars)
Source: Amgevita
Description
A group of TNF inhibitor monoclonal antibody biosimilars recently approved in Singapore. These are indicated for managing conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.
Best for
rheumatoid arthritis patients, Crohn’s disease treatment, psoriatic arthritis care and ulcerative colitis management
View Details
Rating
| Compare | Simponi | Simponi Solution for Injection (Pre-filled Pen/SmartJect) | Amgevita / Yuflyma / Hyrimoz (Adalimumab Biosimilars) |
|---|---|---|---|
| Source | Johnson & Johnson Pte. Ltd. | Johnson & Johnson International (Singapore) Pte Ltd | Amgevita |
| Description | The reference biologic golimumab, a TNF-alpha inhibitor used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. It is available in Singapore as a solution for injection in pre-filled pens (SmartJect) or syringes, and as an intravenous concentrate. | A biological medication containing the active ingredient Golimumab, packaged in the SmartJect pre-filled pen system for subcutaneous injection. This TNF-alpha inhibitor is designed for adult patients suffering from rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. The delivery system is optimized for ease of patient use during self-administration. | A group of TNF inhibitor monoclonal antibody biosimilars recently approved in Singapore. These are indicated for managing conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. |
| Best for | Singapore-based patients, MAF subsidy applicants and rheumatoid arthritis management | home self-administration, rheumatoid arthritis management, ulcerative colitis patients and convenient biologic therapy | rheumatoid arthritis patients, Crohn’s disease treatment, psoriatic arthritis care and ulcerative colitis management |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Simponi from Johnson & Johnson Pte. Ltd.."
I picked this because This is the primary reference product available in Singapore, supported by Health Sciences Authority registration and eligibility for Medication Assistance Fund (MAF) subsidies.
Share this search
Related Finds